Estadístiques de Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
Visites totals
| views | |
|---|---|
| Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial | 151 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 3 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Bellmunt_lo_adju.pdf(legacy) | 158 |
| Bellmunt_lo_adju.pdf | 73 |
Vistes principals per país
| views | |
|---|---|
| United States | 95 |
| South Korea | 13 |
| Germany | 7 |
| Spain | 7 |
| Austria | 3 |
| Hong Kong SAR China | 3 |
| Taiwan | 3 |
| Australia | 2 |
| Belgium | 2 |
| Canada | 2 |
| Japan | 2 |
| Ecuador | 1 |
| France | 1 |
| United Kingdom | 1 |
| Israel | 1 |
| Iran | 1 |
| Italy | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
| Serbia | 1 |
| Sweden | 1 |
| Turkey | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 17 |
| Fairfield | 13 |
| Busan | 9 |
| Barcelona | 7 |
| Ann Arbor | 6 |
| Boardman | 6 |
| Redwood City | 6 |
| Mountain View | 5 |
| Andover | 3 |
| Ashburn | 3 |
| Canton | 3 |
| Conway | 3 |
| Graz | 2 |
| Greensboro | 2 |
| Los Angeles | 2 |
| Menlo Park | 2 |
| Richmond | 2 |
| Rochester | 2 |
| San Diego | 2 |
| Seattle | 2 |
| Cambridge | 1 |
| Charlotte | 1 |
| Falls Church | 1 |
| Gainesville | 1 |
| Jerusalem | 1 |
| Leawood | 1 |
| London | 1 |
| Lucani | 1 |
| Lünen | 1 |
| Nagahama | 1 |
| Oyama | 1 |
| Plainfield | 1 |
| Princeton | 1 |
| Quito | 1 |
| San Antonio | 1 |
| San Francisco | 1 |
| Shah Alam | 1 |
| Stoney Creek | 1 |
| Tainan | 1 |
| Toronto | 1 |
| Vienna | 1 |